Skip to main content
. 2014 Nov 18;2014:342751. doi: 10.1155/2014/342751

Table 1.

Demographics of 30 eligible patients in retrospective study.

Age at entry (years) 46.1 ± 14.8
Gender (M/F) 12/18
Disease extent
 Extensive 5
 Left-sided 12
 Proctitis 13
Dose of prior mesalazine (Pentasa)
 2250 mg 15
 3000 mg 3
 4000 mg 12
Dose of switched mesalazine (Asacol)
 2400 mg 12
 3600 mg 18